A proposed charter for clinical trial data monitoring committees: helping them to do their job well.

Marion Kay Campbell, Adrian Maxwell Grant, Sharon Katrina McCann, Anne Elizabeth Walker, Sheila Ann Wallace, The DAMOCLES Study Group

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

Formal monitoring of data from randomised controlled trials (RCTs) is becoming more common. Wide variation exists in the structure and organisation of data monitoring committees (DMCs), with little guidance on how they should operate. We used various strategies to consider the behavioural, procedural, and organisational aspects of data monitoring in RCTs: systematic reviews of DMCs and small group processes in decision making; surveys of reports of RCTs, recently completed and ongoing RCTs, and the policies of major organisations connected with RCTs; detailed case studies of four DMCs that faced difficult decisions; and interviews with experienced DMC members. The findings aided the development of a template for a charter for DMCs. We summarise the findings and outline the key considerations at every stage of the data monitoring process. Widespread use of a charter for the structure and organisation of DMCs would promote a systematic and transparent approach, and enable them to operate more effectively and efficiently.

Original languageEnglish
Pages (from-to)711-722
Number of pages11
JournalThe Lancet
Volume365
Issue number9460
Publication statusPublished - 2005

Keywords

  • RANDOMIZED CONTROLLED TRIALS
  • CONSORT STATEMENT
  • QUALITY

Cite this

Campbell, M. K., Grant, A. M., McCann, S. K., Walker, A. E., Wallace, S. A., & The DAMOCLES Study Group (2005). A proposed charter for clinical trial data monitoring committees: helping them to do their job well. The Lancet, 365(9460), 711-722.

A proposed charter for clinical trial data monitoring committees: helping them to do their job well. / Campbell, Marion Kay; Grant, Adrian Maxwell; McCann, Sharon Katrina; Walker, Anne Elizabeth; Wallace, Sheila Ann; The DAMOCLES Study Group.

In: The Lancet, Vol. 365, No. 9460, 2005, p. 711-722.

Research output: Contribution to journalArticle

Campbell, MK, Grant, AM, McCann, SK, Walker, AE, Wallace, SA & The DAMOCLES Study Group 2005, 'A proposed charter for clinical trial data monitoring committees: helping them to do their job well.', The Lancet, vol. 365, no. 9460, pp. 711-722.
Campbell MK, Grant AM, McCann SK, Walker AE, Wallace SA, The DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well. The Lancet. 2005;365(9460):711-722.
Campbell, Marion Kay ; Grant, Adrian Maxwell ; McCann, Sharon Katrina ; Walker, Anne Elizabeth ; Wallace, Sheila Ann ; The DAMOCLES Study Group. / A proposed charter for clinical trial data monitoring committees: helping them to do their job well. In: The Lancet. 2005 ; Vol. 365, No. 9460. pp. 711-722.
@article{61433f2c2c4e4822af48407b24d0db77,
title = "A proposed charter for clinical trial data monitoring committees: helping them to do their job well.",
abstract = "Formal monitoring of data from randomised controlled trials (RCTs) is becoming more common. Wide variation exists in the structure and organisation of data monitoring committees (DMCs), with little guidance on how they should operate. We used various strategies to consider the behavioural, procedural, and organisational aspects of data monitoring in RCTs: systematic reviews of DMCs and small group processes in decision making; surveys of reports of RCTs, recently completed and ongoing RCTs, and the policies of major organisations connected with RCTs; detailed case studies of four DMCs that faced difficult decisions; and interviews with experienced DMC members. The findings aided the development of a template for a charter for DMCs. We summarise the findings and outline the key considerations at every stage of the data monitoring process. Widespread use of a charter for the structure and organisation of DMCs would promote a systematic and transparent approach, and enable them to operate more effectively and efficiently.",
keywords = "RANDOMIZED CONTROLLED TRIALS, CONSORT STATEMENT, QUALITY",
author = "Campbell, {Marion Kay} and Grant, {Adrian Maxwell} and McCann, {Sharon Katrina} and Walker, {Anne Elizabeth} and Wallace, {Sheila Ann} and {The DAMOCLES Study Group}",
year = "2005",
language = "English",
volume = "365",
pages = "711--722",
journal = "The Lancet",
issn = "0140-6736",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "9460",

}

TY - JOUR

T1 - A proposed charter for clinical trial data monitoring committees: helping them to do their job well.

AU - Campbell, Marion Kay

AU - Grant, Adrian Maxwell

AU - McCann, Sharon Katrina

AU - Walker, Anne Elizabeth

AU - Wallace, Sheila Ann

AU - The DAMOCLES Study Group

PY - 2005

Y1 - 2005

N2 - Formal monitoring of data from randomised controlled trials (RCTs) is becoming more common. Wide variation exists in the structure and organisation of data monitoring committees (DMCs), with little guidance on how they should operate. We used various strategies to consider the behavioural, procedural, and organisational aspects of data monitoring in RCTs: systematic reviews of DMCs and small group processes in decision making; surveys of reports of RCTs, recently completed and ongoing RCTs, and the policies of major organisations connected with RCTs; detailed case studies of four DMCs that faced difficult decisions; and interviews with experienced DMC members. The findings aided the development of a template for a charter for DMCs. We summarise the findings and outline the key considerations at every stage of the data monitoring process. Widespread use of a charter for the structure and organisation of DMCs would promote a systematic and transparent approach, and enable them to operate more effectively and efficiently.

AB - Formal monitoring of data from randomised controlled trials (RCTs) is becoming more common. Wide variation exists in the structure and organisation of data monitoring committees (DMCs), with little guidance on how they should operate. We used various strategies to consider the behavioural, procedural, and organisational aspects of data monitoring in RCTs: systematic reviews of DMCs and small group processes in decision making; surveys of reports of RCTs, recently completed and ongoing RCTs, and the policies of major organisations connected with RCTs; detailed case studies of four DMCs that faced difficult decisions; and interviews with experienced DMC members. The findings aided the development of a template for a charter for DMCs. We summarise the findings and outline the key considerations at every stage of the data monitoring process. Widespread use of a charter for the structure and organisation of DMCs would promote a systematic and transparent approach, and enable them to operate more effectively and efficiently.

KW - RANDOMIZED CONTROLLED TRIALS

KW - CONSORT STATEMENT

KW - QUALITY

M3 - Article

VL - 365

SP - 711

EP - 722

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9460

ER -